Enzymatic biofungicides with broad efficacy against oomycetes
Lytos Technologies presents an enzymatic biofungicide that effectively combats oomycetes like alternaria, phytophthora, and pythium. Produced via fermentation and stable in various formulations, it outperforms current chemical treatments and poses no risk to pollinators.
Overview
Lytos Technologies has developed a cutting-edge enzymatic biofungicide designed to target a broad spectrum of oomycetes, including alternaria, phytophthora, and pythium. This innovative solution effectively degrades multiple cell wall components, reducing the risk of resistance and offering an eco-friendly alternative to traditional chemical fungicides. The biofungicide is available in both liquid concentrate and dried solid forms, demonstrating flexibility in application and exceeding EPA stability and toxicology requirements, ensuring the lowest risk category with no observed toxicity to pollinators like honeybees.
Technical specifications
- Broad-spectrum efficacy: Targets oomycetes such as alternaria, phytophthora, and pythium.
- Formulation flexibility: Available in liquid concentrate and dried solid forms.
- Environmental safety: Product exceeds EPA stability testing and is categorized under the lowest risk for toxicity, showing no harmful effects on pollinators.
- Production scale: Manufactured using FDA GRAS host Pichia pastoris, with over 1000 L commercial scale production sustained for 5 years.
- Proven superiority: Outperforms Revus and other chemical treatments in independent field trials on crops like tomatoes and wine grapes.
Technology readiness level
This enzymatic biofungicide is at Technology Readiness Level 5, having undergone extensive third-party field trials over several years. It has demonstrated performance that matches or exceeds existing chemical solutions in various crop applications. Future validation efforts will focus on seed treatment applications, with further greenhouse and field trials planned to assess efficacy and stability under different conditions.
About Lytos Technologies, Inc.
Lytos Technologies is a biosolutions platform company that engineers biology to address persistent challenges across water, food, agriculture, and health sectors. The company utilizes its proprietary LytosBI platform, which integrates computational modeling, data-driven design, and molecular biology, to develop technologies that dismantle biofilms and neutralize microbial pathogens. By focusing on fundamental biological mechanisms, Lytos creates targeted alternatives to traditional chemical approaches, aiming to provide solutions that are safer, more sustainable, and capable of performing in complex real-world environments. The company's core scientific foundation stems from research into novel anti-biofilm enzymes, which allow for the advancement of laboratory-validated innovations into scalable, field-ready biosolutions.
The company collaborates with industry, government, and institutional partners, such as the USDA and the University of Virginia, to translate scientific breakthroughs into practical applications. This partnership-driven approach ensures that their developments meet specific real-world requirements for performance, safety, and deployment. By replacing or enhancing conventional chemical methods with biological intelligence, Lytos seeks to resolve critical issues ranging from crop yield protection and food safety to environmental contamination, helping customers and stakeholders manage risks in diverse operating conditions. Through its efforts, the company aims to foster a healthier and more sustainable future by expanding the capabilities of engineered biology.
delivered to your inbox.